🇺🇸 FDA
Pipeline program

Discontinuation antipsychotic treatment

NONSTOP

Phase 3 small_molecule active

Quick answer

Discontinuation antipsychotic treatment for Psychosis Nos/Other is a Phase 3 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Design Therapeutics
Indication
Psychosis Nos/Other
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials